Search research articles
Contact Us
Filters
Showing results (121-130 of 168) with videos related to
Page
of 17
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Transferrin receptor-based circulating tumor cell enrichment provides a snapshot of the molecular landscape of solid tumors and correlates with clinical outcomes
Giuseppe Galletti, Ahmed Halima, Ada Gjyrezi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 14, 2019
Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer
Michael Karass, Rohan Bareja, Ethan Shelkey, et al.
BMC Cancer
|
August 23, 2023
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)
Ariel E Marciscano, Sydney Wolfe, Xi Kathy Zhou, et al.
Communications Biology
|
June 25, 2021
Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage
Ada Gjyrezi, Giuseppe Galletti, Jiaren Zhang, et al.
European Urology
|
September 18, 2012
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity
Himisha Beltran, Roman Yelensky, Garrett M Frampton, et al.
Molecular Cancer Therapeutics
|
March 5, 2020
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy
Vincenza Conteduca, Sheng-Yu Ku, Loredana Puca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Rahul R Aggarwal, Michael T Schweizer, David M Nanus, et al.
JCO Precision Oncology
|
September 3, 2019
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution
Evan M Fernandez, Kenneth Eng, Shaham Beg, et al.
Journal of Translational Medicine
|
January 9, 2007
Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma
Elsa F Velazquez, Molly Yancovitz, Anna Pavlick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2023
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of <sup>225</sup>Ac-J591
Scott T Tagawa, Charlene Thomas, A Oliver Sartor, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 168) with videos related to
Sort By:
Page
of 17
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Transferrin receptor-based circulating tumor cell enrichment provides a snapshot of the molecular landscape of solid tumors and correlates with clinical outcomes
Giuseppe Galletti, Ahmed Halima, Ada Gjyrezi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 14, 2019
Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer
Michael Karass, Rohan Bareja, Ethan Shelkey, et al.
BMC Cancer
|
August 23, 2023
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)
Ariel E Marciscano, Sydney Wolfe, Xi Kathy Zhou, et al.
Communications Biology
|
June 25, 2021
Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage
Ada Gjyrezi, Giuseppe Galletti, Jiaren Zhang, et al.
European Urology
|
September 18, 2012
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity
Himisha Beltran, Roman Yelensky, Garrett M Frampton, et al.
Molecular Cancer Therapeutics
|
March 5, 2020
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy
Vincenza Conteduca, Sheng-Yu Ku, Loredana Puca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Rahul R Aggarwal, Michael T Schweizer, David M Nanus, et al.
JCO Precision Oncology
|
September 3, 2019
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution
Evan M Fernandez, Kenneth Eng, Shaham Beg, et al.
Journal of Translational Medicine
|
January 9, 2007
Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma
Elsa F Velazquez, Molly Yancovitz, Anna Pavlick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2023
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of <sup>225</sup>Ac-J591
Scott T Tagawa, Charlene Thomas, A Oliver Sartor, et al.
Page
of 17